Abstract:CRISPR-Cas (clustered regularly interspaced short palindromic repeats-CRISPR-associated) systems are RNA-guided adaptive immunity pathways used by bacteria and archaea to defend against phages and plasmids. Type III-A systems use a multisubunit interference complex called Csm, containing Cas proteins and a CRISPR RNA (crRNA) to target cognate nucleic acids. The Csm complex is intriguing in that it mediates RNA-guided targeting of both RNA and transcriptionally active DNA, but the mechanism is not well understood. Here, we overexpressed the five components of the Thermus thermophilus (T. thermophilus) Type III-A Csm complex (TthCsm) with a defined crRNA sequence, and purified intact TthCsm complexes from E. coli cells. The complexes were thermophilic, targeting complementary ssRNA more efficiently at 65°C than at 37°C. Sequence-independent, endonucleolytic cleavage of single-stranded DNA (ssDNA) by TthCsm was triggered by recognition of a complementary ssRNA, and required a lack of complementarity between the first 8 nucleotides (5' tag) of the crRNA and the 3' flanking region of the ssRNA. Mutation of the histidine-aspartate (HD) nuclease domain of the TthCsm subunit, Cas10/Csm1, abolished DNA cleavage. Activation of DNA cleavage was dependent on RNA binding but not cleavage. This leads to a model in which binding of an ssRNA target to the Csm complex would stimulate cleavage of exposed ssDNA in the cell, such as could occur when the RNA polymerase unwinds double-stranded DNA (dsDNA) during transcription. Our findings establish an amenable, thermostable system for more in-depth investigation of the targeting mechanism using structural biology methods, such as cryo-electron microscopy and x-ray crystallography.

A type III CRISPR ancillary ribonuclease degrades its cyclic oligoadenylate activator

Molecular mechanism of allosteric activation of the CRISPR ribonuclease Csm6 by cyclic tetra-adenylate

Type III-A CRISPR-associated protein Csm6 degrades cyclic hexa-adenylate activator using both CARF and HEPN domains

Activation and self-inactivation mechanisms of the cyclic oligoadenylate-dependent CRISPR ribonuclease Csm6

Activation of Csm6 ribonuclease by cyclic nucleotide binding: in an emergency, twist to open

A Membrane-Associated DHH-DHHA1 Nuclease Degrades Type III CRISPR Second Messenger

Structural insight into the Csx1-Crn2 fusion self-limiting ribonuclease of type III CRISPR system

Type III CRISPR–Cas systems produce cyclic oligoadenylate second messengers

Type III-B CRISPR-Cas cascade of proteolytic cleavages

Type III-B CRISPR-Cas signaling-based cascade of proteolytic cleavages

Structure and mechanism of a Type III CRISPR defence DNA nuclease activated by cyclic oligoadenylate

Characterization of a novel type III CRISPR-Cas effector provides new insights into the allosteric activation and suppression of the Cas10 DNase.

Csx3 is a cyclic oligonucleotide phosphodiesterase associated with type III CRISPR–Cas that degrades the second messenger cA4

A cyclic oligonucleotide signaling pathway in type III CRISPR-Cas systems

RNA activation‐independent DNA targeting of the Type III CRISPR‐Cas system by a Csm complex

AcrIIIA1 is a protein-RNA anti-CRISPR complex that targets core Cas and accessory nucleases

Diversity and abundance of ring nucleases in type III CRISPR-Cas loci

Bipartite recognition of target RNAs activates DNA cleavage by the Type III-B CRISPR–Cas system

A type III-B CRISPR-Cas effector complex mediating massive target DNA destruction

Cyclic oligoadenylate signalling mediates Mycobacterium tuberculosis CRISPR defence

RNA and DNA Targeting by a Reconstituted Thermus thermophilus Type III-A CRISPR-Cas System